Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Polyethylene Glycols. Found 7 abstracts

Weinberg DS, Lin JE, Foster NR, Della'Zanna G, Umar A, Seisler D, Kraft WK, Kastenberg DM, Katz LC, Limburg PJ, Waldman SA. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer prevention research (Philadelphia, Pa). 2017 Jun;10(6):345-54.   PMCID: PMC5758862
Cheng HA, Drinnan CT, Pleshko N, Fisher OZ. Pseudotannins self-assembled into antioxidant complexes. Soft Matter. 2015 Oct 21;11(39):7783-91.   PMCID: PMC4589535
Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecol Oncol. 2014 Jun;133(3):584-90.
Plimack ER, Desai JR, Issa JP, Jelinek J, Sharma P, Vence LM, Bassett RL, Ilagan JL, Papadopoulos NE, Hwu WJ. A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: Impact on DNA methylation and lymphocyte populations. Investigational New Drugs. 2014 Oct;32(5):969-75.   PMCID: 4171200
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901.   PMCID: PMC4050203
Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009 Mar 20;27(9):1419-25.   PMCID: PMC 2668552
von Mehren M, Schilder RJ, Cheng JD, Temmer E, Cardoso TM, Renshaw FG, Bayever E, Zannikos P, Yuan Z, Cohen RB. A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies. Ann Oncol. 2008 Oct;19(10):1802-9.   PMCID: PMC2598415
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Polyethylene Glycols

Polyethylene Glycols therapeutic use Female drug therapy Doxorubicin Antineoplastic Combined Chemotherapy Protocols Middle Aged drug effects analogs & derivatives Male metabolism administration & dosage pharmacology Aged Cell Survival Recombinant Proteins Neoplasm Staging Tumor Cell Line chemistry Disease-Free Survival Ovarian Neoplasms effects pathology adverse effects immunology dosage chemically induced adverse prevention & control Healthy Volunteers Drug Administration Schedule Paclitaxel genetics Prospective Studies Brca Treatment Outcome Phosphoproteins Cyclic GMP analysis Phosphorylation Gene Expression Profiling Ovarian cancer Tumor-Infiltrating Lymphocytes Epithelial Cells methods Colonoscopy Neoplasms Oral Administration Urinary Bladder Neoplasms Neoadjuvant Therapy Bone Marrow Antineoplastic Antibiotics Colorectal Neoplasms Methotrexate administration & Xenograft Model Antitumor Assays derivatives Kaplan-Meier Estimate T-Lymphocytes Leukocyte Count Neutropenia Gastrointestinal Hormones Peptides Molybdenum diagnostic imaging administration & Antioxidants Dioxoles BRCA1 Genes Guanylyl Cyclase C Agonists analogs & Topotecan Carboplatin Adjuvant Chemotherapy Vinblastine Nephelometry and Turbidimetry Ki-67 Antigen Tannins Melanoma Confocal Microscopy Immunomodulation Tetrahydroisoquinolines Maximum Tolerated Dose Drug Dose-Response Relationship Dynamic Light Scattering DNA Methylation Cell Adhesion Molecules Fatigue Interferon-alpha blood Adult pharmacokinetics Neoplasm Invasiveness Host immunity toxicity Enterotoxin Receptors 80 and over Aged Cisplatin Tungsten Compounds Transitional Cell Carcinoma T cells Microfilament Proteins Peritoneal Neoplasms Filgrastim Deoxycytidine Fourier Transform Infrared Spectroscopy Pegylated Liposomal Doxorubicin Granulocyte Colony-Stimulating Factor Azacitidine Particle Size Mice Natriuretic Peptides Protective Agents Colon Rectum Tumor Biomarkers T-Lymphocyte Subsets Animal Disease Models
Last updated on Wednesday, February 05, 2020